STUDY OF THE DYNAMIC EFFECT OF CHOLESTEROL LOWERING DRUGS USING A MATHEMATICAL MODEL
Artículo
![Thumbnail](/themes/Mirage2/images/cubierta.jpg)
Open/ Download
Publication date
2007Metadata
Show full item record
Cómo citar
Contador, C. A.
Cómo citar
STUDY OF THE DYNAMIC EFFECT OF CHOLESTEROL LOWERING DRUGS USING A MATHEMATICAL MODEL
Author
Abstract
It is widely accepted that cholesterol plays an important role in the infiltration and entrapment
of low density lipoprotein (LDL) in the blood vessel walls (atherogenesis). The transport of
cholesterol and other lipids through the circulatory system is facilitated by their packaging into
lipoprotein carriers such as LDL. In fact, LDL is the major carrier of cholesterol in human
plasma, and therefore it plays a crucial role in atherosclerosis. Small and dense lipoproteins
(sdLDL) are held to be particularly atherogenic.
Fibrates can be used to correct the lipoprotein metabolism disorder associated with sdLDL.
Fibrates act by lowering plasma triacylglycerol and very low density lipoprotein levels (VLDL),
therefore correcting the underlying metabolic disturbance that causes hypercholesterolemia.
A deeper understanding of this system is necessary in order to design more effective drugs. In
this work we present a mathematical model for lipoprotein metabolism. This model was used to
study the effect of Niacin, a fibrate drug, on the levels of VLDL and sdLDLs. Simulations
results show that high levels of triacylglycerol are essential for VLDL accumulation and sdLDL
production. Addition of Niacin reduces triacylglycerol levels. As a result of this the production
of VLDL decreases, which prevents the formation of sdLDL.
Patrocinador
Millenium Institute Initiative, ICM P05-001-F.
Fondecyt Project 1061119.
Identifier
URI: https://repositorio.uchile.cl/handle/2250/125296
Collections